Only two studies formally investigated EASI score performance in people with skin of color (SOC). One virtual study for EASI reliability and validity in 18 patients with SOC used full-body ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

infiltration or papulation, excoriation, and lichenification). The sum of these scores gives the EASI total, which could range from 0 to 72 (the maximum score).

Eczema Area and Severity Index (EASI) score, and Investigator Global Assessment (IGA). The trial targeting 64 patients with ...

Patients treated with the low dose of the antibody showed an average 80% improvement in EASI scores at 16 weeks, compared to 49% in the placebo group, a difference which was "nominally ...